Raj Vuppalanchi MD
Professor of Medicine and Director of Hepatology, Indiana University School of Medicine, Indianapolis, IndianaDr. Raj Vuppalanchi is a tenured Professor of Medicine and holds the position of Director of Hepatology. He became a part of the division in 2007 following the successful completion of dual fellowships in Clinical Pharmacology and Gastroenterology/Hepatology at Indiana University School of Medicine.
With extensive clinical experience, he continues to provide comprehensive care for patients grappling with various liver disorders at the Digestive and Liver Disorder Clinic, located at Indiana University Hospital. His research primarily revolves around patient-centered approaches, with a specific focus on advancing innovative therapies for conditions such as metabolic dysfunction-associated steatohepatitis (MASH), cholestatic and autoimmune liver diseases (including PSC, PBC, and AIH), and cirrhosis.
Dr. Vuppalanchi has made notable contributions in the field of non-invasive tests for assessing the severity of liver disease, employing techniques like transient elastography for liver and spleen stiffness measurements.
Disclosures
Dr. Vuppalanchi receives institutional research grant support from Galectin Therapeutics, Gilead Sciences, Novo Nordisk, Eli Lilly, Astra Zeneca, Zydus Therapeutics Inc, and also discloses consulting for Fortrea, Medpace, Merck, Intercept and GSK.